Showing results (481-490 of 653) with videos related to
Sort By:
Pageof 66
Diabetologia|September 23, 2022
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J Davies, Vanita R Aroda, Billy S Collins, et al.Journal of Clinical Medicine|June 5, 2019
Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System InhibitorsMie K Eickhoff, Claire C J Dekkers, Bart J Kramers, et al.Diabetologia|September 5, 2020
Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuriaSigne A Winther, Peter Henriksen, Josef K Vogt, et al.Journal of Diabetes and Its Complications|May 15, 2024
Extracellular matrix turnover proteins as risk markers in people with type 2 diabetes and microalbuminuriaAnne-Cathrine Skriver-Møller, Alexandra L Møller, Martin B Blond, et al.Diabetes, Obesity & Metabolism|July 4, 2023
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY studyPeter Rossing, Stefan D Anker, Gerasimos Filippatos, et al.Lipids in Health and Disease|September 26, 2023
Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trialsAsger Wretlind, Viktor Rotbain Curovic, Andressa de Zawadzki, et al.Kidney International Reports|June 15, 2026
Post-Hoc Analysis on the Effects of Vicadrostat/Empagliflozin by CKD Severity/Hypertension StatusRicardo Correa-Rotter, Peter Rossing, Maria Eugenia Canziani, et al.Kidney International|August 5, 2019
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney diseasePeter Rossing, Geoffrey A Block, Melanie P Chin, et al.Diabetes Care|September 23, 2022
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J Davies, Vanita R Aroda, Billy S Collins, et al.Journal of Diabetes and Its Complications|October 29, 2024
Effects of probiotics and fibers on markers of nephropathy, inflammation, intestinal barrier dysfunction and endothelial dysfunction in individuals with type 1 diabetes and albuminuria. The ProFOS StudyElisabeth B Stougaard, Ninna Hahn Tougaard, Suvanjaa Sivalingam, et al.Pageof 66